Jazz to acquire Eusa in $700 million deal

Article Date: 27/04/2012 07:44
Jazz to acquire Eusa in $700 million deal

Vacancy Search

Quick job search

Advanced Search

Latest News

PRA Health Sciences cleans up at PharmaTimes Clinical Researcher awards

PRA Health Sciences cleans up at PharmaTimes Clinical Researcher awards

AZ seals immuno-oncology deals as Q1 sales, earnings, slip

AZ seals immuno-oncology deals as Q1 sales, earnings, slip

Currency effects hit Novartis' sales, profit

Currency effects hit Novartis' sales, profit

SMARTTECH: Honey, I shrunk the drugs

SMARTTECH: Honey, I shrunk the drugs

SMARTVIEWS: Off-label but under debate

SMARTVIEWS: Off-label but under debate

Novartis heart drug set for early access in the UK

Novartis heart drug set for early access in the UK

Where is the venture cash going? To the US and giant B rounds

With public markets still buoyant and venture firms raising substantial new funds a bumper first quarter for private biotech financings has followed the record breaking 2014. But where, more...

No hiding from respirageddon for Boehringer

Given the hammering that US prices of respiratory drugs have taken as payers assaulted GlaxoSmithKline’s Advair it might come as a shock that sales of Boehringer Ingelheim’s blockbuster...

Boehringer promises future growth on stale 2014 earnings

Boehringer promises future growth on stale 2014 earnings

UK launch for Revlimid in newly-diagnosed myeloma

UK launch for Revlimid in newly-diagnosed myeloma
more news